Jerome B Zeldis insider trades: Ptc Therapeutics (PTCT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jerome reports to the SEC
and 6 more companies
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | PTCT | ↓ Sell | 24,000 | $51.50 | $1.2M | Direct | Dec 4, 2024 (2d) |
| Nov 20, 2024 | NXGL | ↑ Buy | 3,636 | $2.75 | $10K | Direct | Nov 22, 2024 (2d) |
| Aug 23, 2024 | NXGL | ↑ Buy | 10,000 | $2.50 | $25K | Direct | Aug 27, 2024 (4d) |
| May 22, 2024 | PTCT | ↓ Sell | 20,000 | $38.24 | $765K | Direct | May 24, 2024 (2d) |
| May 26, 2023 | NXGL | ↑ Buy | 5,000 | $2.34 | $12K | Direct | May 30, 2023 (4d) |
| Mar 25, 2022 | NXGL | ↑ Buy | 5,300 | $1.89 | $10K | Direct | Mar 28, 2022 (3d) |
| Dec 27, 2021 | NXGL | ↑ Buy | 9,091 | $5.49 | $50K | Direct | Jan 3, 2022 (7d) |
| May 14, 2021 | SNGX | ↓ Sell | 3,000 | $0.90 | $3K | Direct | May 18, 2021 (4d) |
| May 14, 2021 | SNGX | ↑ Buy | 3,000 | $0.89 | $3K | Direct | May 18, 2021 (4d) |
| Feb 17, 2021 | NEXI | ↑ Buy | 5,882 | $17.00 | $100K | Direct | Feb 19, 2021 (2d) |
| May 28, 2020 | BSGM | ↑ Buy | 1,000 | $10.49 | $10K | Direct | May 28, 2020 (0d) |
| Nov 19, 2019 | SNGX | ↑ Buy | 2,000 | $0.93 | $2K | Direct | Nov 19, 2019 (0d) |
| Sep 19, 2019 | SNGX | ↑ Buy | 4,000 | $0.94 | $4K | Direct | Sep 23, 2019 (4d) |
| Apr 22, 2019 | SNGX | ↑ Buy | 10,000 | $0.73 | $7K | Direct | Apr 22, 2019 (0d) |
| Feb 27, 2017 | ALQA | ↑ Buy | 400,000 | $0.50 | $200K | Direct | Mar 1, 2017 (2d) |
| Feb 3, 2017 | SRNE | ↑ Buy | 10,000 | $5.15 | $52K | Direct | Feb 3, 2017 (0d) |
| Dec 23, 2015 | SNGX | ↑ Buy | 2,500 | $1.27 | $3K | Direct | Dec 23, 2015 (0d) |
| Nov 6, 2015 | ALQA | ↑ Buy | 14,000 | $2.91 | $41K | Direct | Nov 9, 2015 (3d) |
| Jun 25, 2013 | SNGX | ↑ Buy | 23,809 | $1.05 | $25K | Direct | Jun 26, 2013 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PTCT insiders
Open-market trades in the last 12 months
About Jerome B Zeldis's insider trades
Jerome B Zeldis is an insider at Ptc Therapeutics (PTCT). Since Jun 25, 2013, Jerome has reported 16 open-market purchases worth $553K and 3 sales worth $2.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (58 filings), option exercises (8 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.